Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 64,546 | reported | 27 May 2026 | tx 12+402,351−11,331 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 2,175 | 3.98 USD | 10b5-1 |
| 27 May 2026 | SALE | Monte Rosa Therapeutics, Inc. | 2,175 | 20.00 USD | 10b5-1 |
| 27 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 2,175 | 0.00 USD | 10b5-1deriv |
| 22 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 2,176 | 3.98 USD | 10b5-1 |
| 22 May 2026 | SALE | Monte Rosa Therapeutics, Inc. | 2,176 | 19.00 USD | 10b5-1 |
| 22 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 2,176 | 0.00 USD | 10b5-1deriv |
| 05 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 2,629 | 15.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 35,000 | — | |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 158,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 30,000 | — | |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |